SEARCH

SEARCH BY CITATION

References

  • Al-Aqeel S, Al-Sabhan J. (2011) Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsy. Cochrane Database Syst Rev 19:CD008312.
  • Briesacher BA, Andrade SE, Fouayzi H, Chan KA. (2008) Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 28:437443.
  • Burkhart PV, Sabaté E. (2003) Adherence to long-term therapies: evidence for action. J Nurs Scholarsh 35:207.
  • Davis KL, Candrilli SD, Edin HM. (2008) Prevalence and cost of non adherence with antiepileptic drugs in an adult managed care population. Epilepsia 49:446454.
  • De Geest S, Sabaté E. (2003) Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs 2:323.
  • DiIorio C, Reisinger EL, Yeager KA, McCarty F. (2009) A telephone-based self-management program for people with epilepsy. Epilepsy Behav 14:232236.
  • Ettinger AB, Baker GA. (2009) Best clinical and research practice in epilepsy of older people: focus on antiepileptic drug adherence. Epilepsy Behav 15:S60S63.
  • Green LW, Simons-Morton DG. (1988) Denial, delay, and disappointment: discovering and overcoming the causes of drug errors and missed appointments. In Schmidt D, Leppik IE (Eds) Compliance in epilepsy. Elsevier, New York, pp. 721.
  • Hess LM, Raebel MA, Conner DA, Malone DC. (2006) Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 40:12801288.
  • Jones RM, Butler JA, Thomas VA, Peveler RC, Prevett M. (2006) Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure 15:504508.
  • Kwan P, Brodie MJ. (2000) Early Identification of refractory epilepsy. N Engl J Med 342:314319.
  • Leppik IE. (1990) How to get patients with epilepsy to take their medication: the problem of noncompliance. Postgrad Med 88:253256.
  • Liu L, Zhang Q, Yao Z, Wang X, Zhu C, Gao Y, He J, Wang Z, Zhang N, D'Souza W, Zhou D. (2010) The operational model of network for managing patients with convulsive epilepsy in rural West China. Epilepsy Behav 17:7581.
  • Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, Wilson IB. (2008) Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav 12:8694.
  • Manjunath R, Davis KL, Candrilli SD, Ettinger AB. (2009) Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy. Epilepsy Behav 14:372378.
  • Neligan A, Bell GS, Johnson AL, Goodridge DM, Shorvon SD, Sander JW. (2011) The long-term risk of premature mortality in people with epilepsy. Brain 134:388395.
  • Paschal AM, Hawley SR, St Romain T, Ablah E. (2008) Measures of adherence to epilepsy treatment: review of present practices and recommendations for future directions. Epilepsia 49:11151122.
  • Peterson GM, McLean S, Millingen KS. (1984) A randomized trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia 25:412417.
  • Preston CC, Colman AM. (2000) Optimal number of response categories in rating scales: reliability, validity, discriminating power, and respondent preferences. Acta Psychol (Amst) 104:115.
  • Pryse-Phillips W, Jardine F, Bursey F. (1982) Compliance with drug therapy by epileptic patients. Epilepsia 23:269274.
  • Sander JW. (2002) Global campaign against epilepsy. Overview of the demonstration projects. Epilepsia 43(Suppl. 6):3436.
  • Sperling MR. (2004) The consequences of uncontrolled epilepsy. CNS Spectr 9:106109.
  • Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. (1993) The rational clinical examination: is this patient taking the treatment as prescribed? JAMA 269:27792781.
  • Sweileh WM, Ihbesheh MS, Jarar IS, Taha AS, Sawalha AF, Zyoud SH, Jamous RM, Morisky DE. (2011) Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav 21:301305.
  • Walczak TS, Leppik IE, D'Amelio M, Rarick J, So E, Ahman P, Ruggles K, Cascino GD, Annegers JF, Hauser WA. (2001) Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 56:519525.
  • Wang WZ, Wu JZ, Wang DS, Dai XY, Yang B, Wang TP, Yuan CL, Scott RA, Prilipko LL, de Boer HM, Sander JW. (2003) The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology 60:15441545.
  • Wang WZ, Wu JZ, Ma GY, Dai XY, Yang B, Wang TP, Yuan CL, Hong Z, Bell GS, Prilipko L, de Boer HM, Sander JW. (2006) Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China. Lancet Neurol 5:4652.
  • WHO. (2004) Epilepsy in the WHO Africa region, bridging the gap: the global campaign against epilepsy “out of the shadows”. WHO, Geneva.